Home > News > Europe must invest in nanotechnology R&D
January 3rd, 2006
Europe must invest in nanotechnology R&D
Abstract:
A new report warns that as nanotechnology becomes a reality, Europe must not miss the boat, and raises the alarm that the potential benefits of nanomedicine in Europe will be lost without major investment in R&D.
The report, the result of a two-year-long study conducted by the European Science Foundation (ESF), concludes that emerging nanomedicine technologies will increasingly serve as new medical tools for diagnostics and therapeutics in various areas of healthcare including drug discovery and development, drug delivery and providing targeted therapy.
Source:
biopharma-reporter.com
Related News Press |
Possible Futures
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||